Advances in Boston keratoprosthesis: Enhancing retention and prevention of infection and inflammation

International Ophthalmology Clinics

Volumn 47, Issue 2, 2007, Pages 61-71

  Khan, Bilal F ^a   Harissi Dagher, Mona ^a   Khan, Danish M ^a   Dohlman, Claes H ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; ANTIGLAUCOMA AGENT; CARBONATE DEHYDRATASE INHIBITOR; CEFTAZIDIME; CIPROFLOXACIN; CORTICOSTEROID; DEXAMETHASONE; OFLOXACIN; POLYTRIM; PREDNISONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; TOBRAMYCIN; TRIAMCINOLONE; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; CONTACT LENS; CORNEA TRANSPLANTATION; ENDOPHTHALMITIS; EQUIPMENT DESIGN; GLAUCOMA; HUMAN; INFECTION COMPLICATION; INFECTION PREVENTION; INFLAMMATION; KERATOPROSTHESIS; MUCOUS MEMBRANE PEMPHIGOID; PRIORITY JOURNAL; PROGNOSIS; PROSTHESIS INFECTION; RETINA DETACHMENT; RETINA MACULA EDEMA; REVIEW; STEVENS JOHNSON SYNDROME; VITREOUS OPACITY;

CORNEA; ENDOPHTHALMITIS; EYE INFECTIONS; GRAFT SURVIVAL; HUMANS; PROSTHESES AND IMPLANTS; PROSTHESIS DESIGN;

EID: 34248215677     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e318036bd8b     Document Type: Review

References (30)

1. Ma JK, Graney J, Dohlman CH. Repeat penetrating keratoplasty versus the Boston keratoprosthesis in graft failure. Int Ophthalmol Clin. Controversies Ophthalmol. 2005;45:49-59.
2. Yaghouti F, Nouri M, Abad JC, et al. Keratoprosthesis: preoperative prognostic categories. Cornea. 2001;20:19-23.
3. Williams KA, Muehlberg SM, Lewis RF, et al. How successful is corneal transplantation? A report from the Australian Corneal Graft Register. Eye. 1995;9:219-227.
4. Berudsky V, Blum-Hareuveni T, Rehany U, et al. The profile of repeat corneal transplantation. Ophthalmology. 2001;108:461-469.
5. Pellier de Quengsy G. Precis ou cours d'operation sur la chirurgie des yeux. Paris: Didot; 1789.
6. Khan BF, Harissi-Dagher M, Dohlman CH. Keratoprosthesis. In: Albert D, Miller J, eds. Albert and Jakobiec's Principles and Practice of Ophthalmology. 3rd ed. Philadelphia: WB Saunders. In press.
7. Strampelli B. Osteo-odontokeratoprosthesis. Ann Ottalmol Clin Ocul. 1963;89:1039-1044.
8. Liu C, Herold J, Sciscio A, et al. Osteon-odonto-keratoprosthesis surgery. Br J Ophthalmol. 1999;83:127.
9. Pintucci S, Pintucci F, Cecconi M, et al. The Dacron felt colonizable keratoprosthesis: after 15 years. Eur J Ophthalmol. 1996;6:125-130.
10. Crawford GJ, Hicks CR, Lou X, et al. The chirila keratoprosthesis: phase I human clinical trial. Ophthalmology. 2002;109:883-889.
11. Cardona H. The cardona keratoprosthesis: 40 years experience. Refract Corneal Surg. 1991;7:468-471.
12. Dohlman CH, Schneider HA, Doane MG. Prosthokeratoplasty. Am J Ophthalmol. 1974;77:694-670.
13. Barraquer J. Keratoplasty and keratoprosthesis. Pocklington Memorial Lecture delivered at the Royal College of Surgeons of England on 5th May, 1966. Ann R Coll Surg Engl. 1967;40:71-81.
14. Doane MG, Dohlman CH, Bearse G. Fabrication of a keratoprosthesis. Cornea. 1996;15:179-184.
15. Dohlman CH. Post operative regimen and repair of complications after keratoprosthesis surgery. Refract Corneal Surg. 1993;9:198.
16. Throft RA, Friend J, Dohlman CH. Corneal glucose flux. II. Its response to anterior chamber blockade and endothelial damage. Arch Ophthalmol. 1971;86:685-691.
17. Dohlman CH, Dudenhoefer EJ, Khan BF, et al. Protection of the ocular surface after keratoprosthesis surgery: the role of soft contact lenses. CLAO J. 2002;28:72-74.
18. Barnham JJ, Roper-Hall MJ. Keratoprosthesis a long term view. Br J Ophthalmol. 1983;67:468-474.
19. Alvarez de Toledo J, Barraquer RI, Temprano J, et al. Osteo-odonto-keratoprosthesis: a 30-year retrospective study. An Inst Barraquer. 1999;28(suppl):95-100.
20. Cardona H, De Voe AC. Postkeratoplasty. Trans Am Acad Ophthalmol. 1977;83:271-280.
21. Nouri M, Terada H, Alfonso EC, et al. Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol. 2001;119:484-489.
22. The Endophthalmitis Vitrectomy Study Group. Microbiological factors and visual outcome in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol. 1996;122:830-846.
23. Dohlman CH, Nouri M, Barnes S, et al. Prophylactic antibiotic regimens in keratoprosthesis. Invest Ophthalmol Vis Sci. 2003;1455-B351. ARVO abstract.
24. Durand M, Dohlman CH. Use of prophylactic vancomycin in Boston keratoprosthesis. In preparation.
25. Bath PE, McCord RC, Cox KC. Nd: YAG laser discussion of retro keratoprosthetic membrane: a preliminary report. Cornea. 1983;2:225-228.
26. Nouri M, Durand ML, Dohlman CH. Sudden reversible vitritis after keratoprosthesis. An immune phenomenon? Cornea. 2005;24:915-919.
27. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113:1479-1496.
28. Netland PA, Terada H, Dohlman CH. Glaucoma associated with keratoprosthesis. Ophthalmology. 1998;105:751-757.
29. Dohlman CH, Terada H. Keratoprosthesis in pemphigoid and Stevens-Johnson syndrome. In: Sullivan D, ed. Lacrimal Gland, Tear Film and Dry Eye Syndromes II. Basic Science and Clinical Relevance. Adv Exp Med Biol. New York: Plenium Publishing; 1998;438:1021-1025.
30. Ray S, Khan BF, Dohlman CH, et al. Management of vitreoretinal complications in eyes with permanent keratoprosthesis. Arch Ophthalmol. 2002;120:559-566.